7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene

C54H29N5 — CID 169056375

IUPAC7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene
SMILESc1ccc(-n2c3ccccc3c3cc(-c4cccc5c6cccc7c8nc9c(nc8n(c45)c67)c4cc5ccccc5c5c6c7ccccc7ccc6n9c45)ccc32)cc1
InChIInChI=1S/C54H29N5/c1-2-14-33(15-3-1)57-43-23-9-8-18-37(43)41-28-32(25-26-44(41)57)36-19-10-20-38-39-21-11-22-40-48-54(59(50(36)38)51(39)40)56-49-42-29-31-13-5-7-17-35(31)47-46-34-16-6-4-12-30(34)24-27-45(46)58(52(42)47)53(49)55-48/h1-29H
InChIKeyQHFDGYPGSGPPCY-UHFFFAOYSA-N
MW747.86 g/mol
LogP13.85
Rot. Bonds2

About 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene

7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene (PubChem CID 169056375) has the molecular formula C54H29N5 and a molecular weight of 747.86 g/mol. Its IUPAC name is 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene.

Molecular Properties

Compound Name7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene
PubChem CID169056375
Molecular FormulaC54H29N5
Molecular Weight747.86 g/mol
Exact Mass747.24
IUPAC Name7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene
SMILESc1ccc(-n2c3ccccc3c3cc(-c4cccc5c6cccc7c8nc9c(nc8n(c45)c67)c4cc5ccccc5c5c6c7ccccc7ccc6n9c45)ccc32)cc1
InChIInChI=1S/C54H29N5/c1-2-14-33(15-3-1)57-43-23-9-8-18-37(43)41-28-32(25-26-44(41)57)36-19-10-20-38-39-21-11-22-40-48-54(59(50(36)38)51(39)40)56-49-42-29-31-13-5-7-17-35(31)47-46-34-16-6-4-12-30(34)24-27-45(46)58(52(42)47)53(49)55-48/h1-29H
InChIKeyQHFDGYPGSGPPCY-UHFFFAOYSA-N
XLogP13.85
TPSA39.53 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500747.86
LogP ≤ 513.85
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene?
The IUPAC name of 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene (CID 169056375) is 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene.
What is the SMILES notation for 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene?
The canonical SMILES for 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene is c1ccc(-n2c3ccccc3c3cc(-c4cccc5c6cccc7c8nc9c(nc8n(c45)c67)c4cc5ccccc5c5c6c7ccccc7ccc6n9c45)ccc32)cc1.
What is the InChIKey of 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene?
The InChIKey is QHFDGYPGSGPPCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H29N5/c1-2-14-33(15-3-1)57-43-23-9-8-18-37(43)41-28-32(25-26-44(41)57)36-19-10-20-38-39-21-11-22-40-48-54(59(50(36)38)51(39)40)56-49-42-29-31-13-5-7-17-35(31)47-46-34-16-6-4-12-30(34)24-27-45(46)58(52(42)47)53(49)55-48/h1-29H.
What are the key properties of 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene?
7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene has a molecular weight of 747.86 g/mol, XLogP of 13.85, 2 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 7-(9-phenylcarbazol-3-yl)-3,5,18,20-tetrazaundecacyclo[18.18.1.15,12.02,19.04,17.06,11.021,30.024,29.031,39.032,37.016,40]tetraconta-1(38),2,4(17),6(11),7,9,12(40),13,15,18,21(30),22,24,26,28,31(39),32,34,36-nonadecaene is sourced from PubChem (CID 169056375), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).